SCHEMBL4751031

SCHEMBL4751031

CC(C)(C)OC(=O)N1CCN(Cc2cccnc2Nc2cc(Cl)cc(Cl)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
VEGFA P15692 1/20 0.46
EGLN1 Q9GZT9 1/20 0.46
MAPT P10636 2/20 0.44
MPI P34949 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CCNK O75909 1/20 0.44
CDK12 Q9NYV4 1/20 0.44
TBK1 Q9UHD2 2/20 0.43
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
ALDH1A1 P00352 2/20 0.42
STS P08842 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
KDR P35968 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13982544 0.87 NPSR1 (0.42) MAPTMPIKMT2AMEN1NPC1
SCHEMBL4752749 0.85 NPSR1 (0.46) MAPTMPIKMT2AMEN1NPC1
SCHEMBL4753342 0.84 MAPT (0.49) POLBMAPTMPIKMT2AMEN1
SCHEMBL4754202 0.83 MAPT (0.44) POLBMAPTMPIKMT2AMEN1
SCHEMBL4753314 0.83 NPSR1 (0.46) MAPTMPIKMT2AMEN1NPC1
SCHEMBL4750973 0.82 MAPT (0.45) POLBMAPTMPIKMT2AMEN1
SCHEMBL4750763 0.79 ADORA3 (0.44) POLBMAPTMPIKMT2AMEN1
SCHEMBL4750997 0.79 MAPT (0.42) POLBMAPTMPIKMT2AMEN1
SCHEMBL4751010 0.79 MAPT (0.44) POLBMAPTMPIKMT2AMEN1
SCHEMBL4753123 0.79 CHRM3 (0.46) MAPTMPIKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed
WO-2007109324-A2 POTENT AND SELECTIVE NAV 1.7 SODIUM CHANNEL BLOCKERS XENON PHARMACEUTICALS, INC. (CA) 2007-09-27 WO disclosed